Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Santosh L. Saraf, MD, Vimal K. Derebail, MD, Xu Zhang, PhD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2268.

https://doi.org/10.1182/blood-2019-124737

Published: 2019

Journal Articles

Phosphorus Levels in Iron Deficient Children Treated with Ferric Carboxymaltose

Susan Kirk, PA-C, Donald Mahoney, MD, Melanie Brooke Bernhardt, PharmD, Jacquelyn M. Powers, MD,MSc

Blood (2019) 134 (Supplement_1): 2240.

https://doi.org/10.1182/blood-2019-129159

Published: 2019

Journal Articles

Dual Anticoagulant Facilitied Peripheral Blood Stem Cell Harvest from Childhood Donors with Low Weight and Low MCV

Li Yue, Chaoke Bu, Zhirui Ma, Chunfu Li, MD, Wenjun Wang, Jun Zhou

Blood (2019) 134 (Supplement_1): 5639.

https://doi.org/10.1182/blood-2019-129585

Published: 2019

Journal Articles

Serum Electrolyte Dynamics in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Apoorva Anandan, MD, Pingfu Fu, Merle Kolk, Nicole Ferrari, Arash Rashidi, MD, Melissa Copley, PharmD, James Driscoll, MD PhD, Paolo Caimi, MD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2019) 134 (Supplement_1): 5646.

https://doi.org/10.1182/blood-2019-122057

Published: 2019

Journal Articles

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

Vandana Sachdev, MD, Yuan Gu, PhD, James Nichols, RN, Wen Li, RCS, Stanislav Sidenko, RCS, Darlene Allen, MT(ASCP), Colin Wu, PhD, Swee Lay Thein, DSc, MBBS

Blood (2019) 134 (Supplement_1): 893.

https://doi.org/10.1182/blood-2019-125846

Published: 2019

Journal Articles

Evaluation of Phenotype-Genotype Correlation in Two Common PIEZO1 Mutations p.R2456H and p.L2495_E2495dup

Mary Risinger, PhD, Vandy Black, MDMSc, Loan Hsieh, MD, Renee C. Prins, MD, Jill Menell, MD, Mohamad Badawi, MD, Cynthia Rutherford, MD, Karen L. Bride, MD PhD, Omar Niss, MD, Charles T. Quinn, MD, Katie Giger Seu, PhD, Wenying Zhang, MDPhD, Theodosia A. Kalfa, MD PhD

Blood (2018) 132 (Supplement 1): 1040.

https://doi.org/10.1182/blood-2018-99-117299

Published: 2018

Journal Articles

Safety and Efficacy of Single-Dose Intravenous Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients with Hematooncological Malignancies after Moderate and High Emetogenic Chemotherapy

Semjon Willier, MD, Karin Melanie Cabanillas Stanchi, MSc, Martha von Have, Dr. MD, Vera Binder, Dr. MD, Franziska Blaeschke, Dr. MD, Tobias F. Feuchtinger, Prof. Dr. MD, Michaela Döring, Dr. MD

Blood (2017) 130 (Supplement 1): 3220.

https://doi.org/10.1182/blood.V130.Suppl_1.3220.3220

Published: 2017

Journal Articles

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Mahesh Swaminathan, MD, Hagop M. Kantarjian, MD, Naval Daver, MD, Gautam Borthakur, MD, Maro Ohanian, DO, Tapan Kadia, MD, Courtney D. DiNardo, MDMSc, Nitin Jain, MD, Zeev Estrov, MD, Alessandra Ferrajoli, MD, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Michael Andreeff, MD PhD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, William G Wierda, MD PhD, Farhad Ravandi, MBBS, Maria Rhona Pinsoy, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 723.

https://doi.org/10.1182/blood.V130.Suppl_1.723.723

Published: 2017

Journal Articles

Preliminary Detection of Leukemia with Blood By a Novel Electrochemical Method

Yujie Wang, Baoan Chen, MD PhD Professor, Zheng Ge, MD PhD

Blood (2016) 128 (22): 5902.

https://doi.org/10.1182/blood.V128.22.5902.5902

Published: 2016

Journal Articles

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Waleed Abdelall, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Keyur P. Patel, MD PhD, Elias J. Jabbour, MD, Naval G. Daver, MD, Tapan Kadia, MD, Rosilyn A. Gborogen, RN, Marina Konopleva, MD PhD, Farhad Ravandi, MD, Michael Andreef, MD PhD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 1642.

https://doi.org/10.1182/blood.V128.22.1642.1642

Published: 2016

Journal Articles

Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study

Marie Y Detrait, MD, Stéphane Morisset, Stat, Anne Beatrice Notarantonio, Pochon Cecile, Sabine Cohen, Catherine Rioufol, PharmD, Gabrielle Roth Guepin, Maud D'Aveni, Adele Dhuyser, Sylvie Tarillon, Chapel Valerie, Marie t Rubio, MDPhD, Barraco Fiorenza, Mauricette Michallet, MD PhD

Blood (2016) 128 (22): 5749.

https://doi.org/10.1182/blood.V128.22.5749.5749

Published: 2016

Journal Articles

Inhibition of CML Stem Cells with an Alkaloid That Reduces β-Catenin

Shawnya J. Michaels, MS,MBA, Ngoc DeSouza, PhDCandidate, Yi Shan, MD, Shaoguang Li, MD PhD, Saira Bates, MBA

Blood (2016) 128 (22): 1882.

https://doi.org/10.1182/blood.V128.22.1882.1882

Published: 2016

Journal Articles

Outcome and Prognostic Factors of Patients with Hematological Malignancies Admitted to an Intensive Care Unit

Pak Ling Lui, MBBS, MRCP, Rakshya Pandey, MBBS, MRCP, Jonathan Tian En Koh, Eng Soo Yap, MBBS, MRCP, Amartya Mukhopadhyay, MBBS, MRCP, Wee Joo Chng, MB ChB, MRCP, PhD

Blood (2016) 128 (22): 4796.

https://doi.org/10.1182/blood.V128.22.4796.4796

Published: 2016

Journal Articles

Venetoclax (VEN) Monotherapy for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapsed after or Were Refractory to Ibrutinib or Idelalisib

Jeffrey Jones, Michael Y. Choi, MD, Anthony R. Mato, Richard R. Furman, Matthew S. Davids, Leonard T. Heffner, MD, Bruce D. Cheson, Nicole Lamanna, MD, Paul M. Barr, Herbert Eradat, Ahmad Halwani, Brenda Chyla, Ming Zhu, Maria Verdugo, Rod A. Humerickhouse, MD, Jalaja Potluri, William G. Wierda, MD PhD, Steven E. Coutre, MD

Blood (2016) 128 (22): 637.

https://doi.org/10.1182/blood.V128.22.637.637

Published: 2016

Journal Articles

Dissecting Antigen-Specific T-Cell Immunity in Human Cancer and Acquired Resistance to Immunotherapy

Nicholas Restifo, MD

Blood (2016) 128 (22): SCI-12.

https://doi.org/10.1182/blood.V128.22.SCI-12.SCI-12

Published: 2016

Journal Articles

Detection of Familial Pseudohyperkalemia Among Italian Blood Donors By Genetic Screening for the R276W Mutation in ABCB6

Immacolata Andolfo, Roberta Russo, Francesco Manna, Marica Lisa Salve, Alok K. Sharma, Seth L. Alper, Lucia De Franceschi, MD, Achille Iolascon, MD PhD

Blood (2015) 126 (23): 2132.

https://doi.org/10.1182/blood.V126.23.2132.2132

Published: 2015

Journal Articles

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II Trial

Georg Hess, MD, Ulrich Keller, Johannes Atta, Ulrich Bitz, MD, Christian Lerchenmueller, Wagner Karola, Christoph Medler, Christian Ruckes, Mathias Witzens-Harig, MD, Kai Huebel, Paul LaRosee, Martin H. Dreyling, MD PhD

Blood (2015) 126 (23): 3930.

https://doi.org/10.1182/blood.V126.23.3930.3930

Published: 2015

Journal Articles

Oxidative Stress Contributes to Overactive Bladder in the Transgenic Sickle Cell Mouse

Fabio Henrique Silva, M.Sc, PhD, Celso Saragosa Ramos Filho, PhD, Fabiano Beraldi Calmasini, M.Sc, Eduardo Costa Alexandre, M.Sc, Roger Barbosa Ferreira, Mariana Goncalves de Oliveira, M.Sc, Mário Angelo Claudino, BSc, PhD, Carla Fernanda Franco-Penteado, BSc, PhD, Edson Antunes, PhD, Fernando F Costa, MD, PhD

Blood (2015) 126 (23): 4582.

https://doi.org/10.1182/blood.V126.23.4582.4582

Published: 2015

Journal Articles

Preliminary Results of a Phase 2, Open-Label Study of Venetoclax (ABT-199/GDC-0199) Monotherapy in Patients with Chronic Lymphocytic Leukemia Relapsed after or Refractory to Ibrutinib or Idelalisib Therapy

Jeffrey Jones, MD, Anthony R. Mato, MD, Steven Coutre, MD, William Wierda, MD PhD, Michael Y. Choi, MD, Matthew S. Davids, MD, Nicole Lamanna, MD, Paul Barr, MD, Kim Burns, BA, Nicholas Montalvo, MBA, Ming Zhu, PhD, Todd Busman, MS, Jalaja Potluri, MD FACP, Rod A. Humerickhouse, MD PhD, John C. Byrd, MD

Blood (2015) 126 (23): 715.

https://doi.org/10.1182/blood.V126.23.715.715

Published: 2015

Journal Articles

A mutation in the Gardos channel is associated with hereditary xerocytosis

Blood (2015) 126 (11): 1273–1280.

https://doi.org/10.1182/blood-2015-04-642496

Published: 2015

NARROW

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Phosphorus Levels in Iron Deficient Children Treated with Ferric Carboxymaltose

Dual Anticoagulant Facilitied Peripheral Blood Stem Cell Harvest from Childhood Donors with Low Weight and Low MCV

Serum Electrolyte Dynamics in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

A Machine Learning Algorithm to Improve Risk Assessment for Patients with Sickle Cell Disease

Evaluation of Phenotype-Genotype Correlation in Two Common PIEZO1 Mutations p.R2456H and p.L2495_E2495dup

Safety and Efficacy of Single-Dose Intravenous Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients with Hematooncological Malignancies after Moderate and High Emetogenic Chemotherapy

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Preliminary Detection of Leukemia with Blood By a Novel Electrochemical Method

The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial

Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study

Inhibition of CML Stem Cells with an Alkaloid That Reduces β-Catenin

Outcome and Prognostic Factors of Patients with Hematological Malignancies Admitted to an Intensive Care Unit

Venetoclax (VEN) Monotherapy for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapsed after or Were Refractory to Ibrutinib or Idelalisib

Dissecting Antigen-Specific T-Cell Immunity in Human Cancer and Acquired Resistance to Immunotherapy

Detection of Familial Pseudohyperkalemia Among Italian Blood Donors By Genetic Screening for the R276W Mutation in ABCB6

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II Trial

Oxidative Stress Contributes to Overactive Bladder in the Transgenic Sickle Cell Mouse

Preliminary Results of a Phase 2, Open-Label Study of Venetoclax (ABT-199/GDC-0199) Monotherapy in Patients with Chronic Lymphocytic Leukemia Relapsed after or Refractory to Ibrutinib or Idelalisib Therapy

A mutation in the Gardos channel is associated with hereditary xerocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only